Company Analysis

Artelo Biosciences, Inc. (ARTL)

Nasdaq: ARTL · Pharmaceutical Preparations · Solana Beach, CA · filing with the SEC since 2014
Grade4.6
◀ Past 4.6● Present 4.3▶ Future 4.8
6 est.

Filings

346 filings since 2017 beside 101 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 76 days after the quarter ended. The proxy statement was last filed Jun 5, 2026.

Filings a yearinsider forms included
6064463331256077
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Jan 16, 2026.Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Oct 27, 2025.SEC letters: 11 in the last 36 months, the newest May 15, 2026.
Insider forms 101

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Oct 9, 2026 8-K item 8.01 Other event · Current report
Aug 27, 2026 8-K items 3.03, 5.03, 7.01, 9.01 Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report Aug 26, 2026
Aug 20, 2026 10-Q/A Quarterly report, amended Jun 30, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2026 10-Q Quarterly report Jun 30, 2026
Jul 17, 2026 8-K item 5.07 Shareholder vote · Current report
Jul 16, 2026 DEFA14A Extra proxy material
Jul 16, 2026 DEFA14A Extra proxy material
Jul 2, 2026 DEFA14A Extra proxy material
Jun 22, 2026 PRER14A Form PRER14A
Jun 5, 2026 ARS Annual report to shareholders Dec 31, 2025
Jun 5, 2026 DEFA14A Extra proxy material
Jun 5, 2026 DEF 14A Proxy statement Jul 17, 2026
May 27, 2026 8-K items 1.01, 8.01, 9.01 Major agreement signed; Other event · Current report May 26, 2026
May 26, 2026 PRE 14A Preliminary proxy statement Jul 17, 2026
May 26, 2026 424B5 Shelf offering
May 19, 2026 EFFECT Registration effective
May 18, 2026 424B5 Shelf offering
May 15, 2026 CORRESP Reply to the SEC
May 15, 2026 8-K item 1.02 Major agreement ended · Current report May 11, 2026
May 15, 2026 SCHEDULE 13G Large holder notice
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 S-3/A Shelf registration, amended
May 11, 2026 UPLOAD SEC comment letter
May 4, 2026 S-3 Shelf registration
Apr 16, 2026 424B3 Shelf offering
Apr 15, 2026 EFFECT Registration effective
Apr 13, 2026 CORRESP Reply to the SEC
Apr 13, 2026 UPLOAD SEC comment letter
Apr 7, 2026 S-1 Listing registration
Apr 7, 2026 8-K items 8.01, 9.01 Other event · Current report Apr 6, 2026
Apr 6, 2026 D Private placement notice
Apr 3, 2026 SCHEDULE 13G Large holder notice
Mar 30, 2026 EFFECT Registration effective
Mar 30, 2026 8-K items 1.01, 3.02, 7.01, 8.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD); Other event · Current report Mar 27, 2026
Mar 27, 2026 RW Registration withdrawal request
Mar 27, 2026 D Private placement notice
Mar 27, 2026 D Private placement notice
40 of 346 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ARTL · research, not advice